Blog: Opioid epidemic - The pain persists

pills drugs pharmaceuticals

A Sunday Times investigation recently revealed Britain is in danger of replicating the painkiller epidemic that has ravaged the US — particularly in the north, where the drugs are prescribed four times more than in London. Dorothy Flower, partner, and Emma Kislingbury, associate at RPC, explore how this might impact pharmaceutical companies, medical practitioners, healthcare providers, and their insurers.

‘Epidemic’, ‘crisis’, ‘timebomb’; these are, unfortunately, all too familiar terms used to describe the impact opioids - a class of drugs that include the illegal drug heroin, synthetic opioids such

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here